Our research focusses on the development of early assessment and intervention strategies targeted at age-associated degenerative conditions. Our two main focuses are on Dementia and Parkinson’s disease.
Dementia refers to a progressive loss of cognitive abilities, such that the person has difficulty undertaking routine daily tasks. Dementia can affect a number of functions, such as memory, reasoning and communication skills.
There are currently 700,000 people in the UK with dementia, and the number of people with this condition will double to 1.4 million in the next 30 years.
Alzheimer’s disease, vascular dementia and dementia with Lewy bodies are common types of dementia. A greater understanding of the processes underlying nerve cell loss in the different dementia is translating into several exciting and novel therapeutic areas.
Parkinson’s disease affects 1% of the population over the age of 65, but can also develop in people at a much younger age. Parkinson’s disease leads to problems with tremors, stiffness and slowness
of movement. It can also be associated with a number of other “non-motor” symptoms, including depression, sleep disturbance and cognitive abilities (including dementia in some cases).
There are effective symptomatic drug treatments available for many aspects of Parkinson’s disease, although there are still many areas of unmet need.